Nordisk Pharma ApS — Credit Rating and Financial Key Figures
CVR number: 42852287
Stenkløvervænget 21, 2625 Vallensbæk
Income statement (kDKK)
2022 | 2023 | 2024 | |
|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 |
| Net sales | |||
| Gross profit | -18.80 | 331.91 | 552.86 |
| EBIT | -18.80 | 331.91 | 552.86 |
| Other financial expenses | -0.20 | -5.84 | |
| Pre-tax profit | -19.00 | 331.91 | 547.03 |
| Income taxes | -68.93 | - 121.51 | |
| Net earnings | -19.00 | 262.98 | 425.52 |
Assets (kDKK)
2022 | 2023 | 2024 | |
|---|---|---|---|
| Intangible assets total | |||
| Tangible assets total | |||
| Investments total | |||
| Long term receivables total | |||
| Raw materials and consumables | 60.38 | 42.84 | |
| Inventories total | 60.38 | 42.84 | |
| Current trade debtors | 250.12 | 200.21 | |
| Current other receivables | 0.58 | ||
| Short term receivables total | 0.58 | 250.12 | 200.21 |
| Cash and bank deposits | 320.44 | 436.10 | 1 064.64 |
| Cash and cash equivalents | 320.44 | 436.10 | 1 064.64 |
| Balance sheet total (assets) | 321.02 | 746.60 | 1 307.70 |
Equity and liabilities (kDKK)
2022 | 2023 | 2024 | |
|---|---|---|---|
| Share capital | 340.00 | 340.00 | 340.00 |
| Retained earnings | -19.00 | 243.98 | |
| Profit of the financial year | -19.00 | 262.98 | 425.52 |
| Shareholders equity total | 321.00 | 583.98 | 1 009.50 |
| Non-current liabilities total | |||
| Current trade creditors | 16.25 | 42.06 | |
| Short-term deferred tax liabilities | 68.93 | 121.51 | |
| Other non-interest bearing current liabilities | 0.03 | 77.45 | 134.62 |
| Current liabilities total | 0.03 | 162.62 | 298.19 |
| Balance sheet total (liabilities) | 321.02 | 746.60 | 1 307.70 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.